Document is current

Any future updates will be listed below

Represcription of Low-Dose Acetylsalicylic Acid After Discontinuation in Patients Receiving Treatment for Secondary Cardiovascular Disease Prevention in the UK

Crossref DOI link: https://doi.org/10.1007/s40256-014-0079-y

Published Online: 2014-06-11

Published Print: 2014-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark